Kidswell Bio Corporation
4584.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥5,082 | ¥2,431 | ¥2,776 | ¥1,569 |
| % Growth | 109% | -12.4% | 76.9% | – |
| Cost of Goods Sold | ¥3,443 | ¥1,392 | ¥1,251 | ¥550 |
| Gross Profit | ¥1,639 | ¥1,039 | ¥1,526 | ¥1,019 |
| % Margin | 32.3% | 42.8% | 55% | 64.9% |
| R&D Expenses | ¥768 | ¥1,453 | ¥1,216 | ¥903 |
| G&A Expenses | ¥207 | ¥164 | ¥183 | ¥102 |
| SG&A Expenses | ¥207 | ¥164 | ¥183 | ¥102 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥636 | ¥758 | ¥677 | ¥665 |
| Operating Expenses | ¥1,611 | ¥2,375 | ¥2,077 | ¥1,670 |
| Operating Income | ¥28 | -¥1,336 | -¥551 | -¥651 |
| % Margin | 0.5% | -54.9% | -19.8% | -41.5% |
| Other Income/Exp. Net | ¥45 | -¥85 | -¥105 | ¥101 |
| Pre-Tax Income | ¥73 | -¥1,421 | -¥656 | -¥550 |
| Tax Expense | ¥94 | ¥2 | ¥1 | ¥1 |
| Net Income | -¥21 | -¥1,422 | -¥657 | -¥551 |
| % Margin | -0.4% | -58.5% | -23.7% | -35.1% |
| EPS | -0.52 | -40.23 | -20.77 | -17.86 |
| % Growth | 98.7% | -93.7% | -16.3% | – |
| EPS Diluted | -0.52 | -40.23 | -20.77 | -17.86 |
| Weighted Avg Shares Out | 41 | 35 | 32 | 31 |
| Weighted Avg Shares Out Dil | 41 | 35 | 32 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥1 | ¥0 | ¥0 | ¥1 |
| Interest Expense | ¥42 | ¥39 | ¥35 | ¥15 |
| Depreciation & Amortization | ¥1 | ¥1 | ¥1 | ¥2 |
| EBITDA | ¥116 | -¥1,381 | -¥620 | -¥532 |
| % Margin | 2.3% | -56.8% | -22.3% | -33.9% |